Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Yale University
New Haven, Connecticut
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 144
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
NameCraig Crews | TypeConflict of Interest | CompanyHalda Therapeutics OpCo | Disclosed Value$200,000 - $249,999 | Year Filed2019 |
NameLaura Niklason | TypeConflict of Interest | CompanyHumacyte, Inc. | Disclosed Value$150,000 - $199,999 | Year Filed2016 |
NameLaura Niklason | TypeConflict of Interest | CompanyHumacyte, Inc. | Disclosed Value$150,000 - $199,999 | Year Filed2017 |
NameLaura E. Niklason | TypeConflict of Interest | CompanyHumacyte, Inc. | Disclosed Value$150,000 - $199,999 | Year Filed2016 |
NameLaura Niklason | TypeConflict of Interest | CompanyHumacyte, Inc. | Disclosed Value$100,000 - $149,999 | Year Filed2017 |
NameCraig Crews | TypeConflict of Interest | CompanyArvinas, LLC | Disclosed Value$80,000 - $99,999 | Year Filed2015 |
NameCraig Crews | TypeConflict of Interest | CompanyArvinas, Inc. (formerly Arvinas, LLC) | Disclosed Value$80,000 - $99,999 | Year Filed2014 |
NameJean-Francois Geschwind | TypeConflict of Interest | CompanyBTG International, Inc. | Disclosed Value$60,000 - $79,999 | Year Filed2015 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyInsuline Medical, Ltd. | Disclosed Value$60,000 - $79,999 | Year Filed2014 |
NameYung-Chi Cheng | TypeConflict of Interest | CompanyKadmon Corporation | Disclosed Value$60,000 - $79,999 | Year Filed2013 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyInsuline Medical, Ltd. | Disclosed Value$60,000 - $79,999 | Year Filed2014 |
NameAna C. Anderson | TypeConflict of Interest | CompanyPotenza Therapeutics | Disclosed Value$40,000 - $59,999 | Year Filed2017 |
NameMichael Girardi | TypeConflict of Interest | CompanyNanosive | Disclosed Value$40,000 - $59,999 | Year Filed2018 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyInsuline Medical, Ltd. | Disclosed Value$40,000 - $59,999 | Year Filed2014 |
NameW. Mark Saltzman | TypeConflict of Interest | CompanyNanosive | Disclosed Value$40,000 - $59,999 | Year Filed2018 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyInsuline Medical, Ltd. | Disclosed Value$40,000 - $59,999 | Year Filed2014 |
NameCraig Crews | TypeConflict of Interest | CompanyCanaan Partners | Disclosed Value$40,000 - $59,999 | Year Filed2014 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyNovo Nordisk Pharmaceuticals | Disclosed Value$20,000 - $39,999 | Year Filed2014 |
NamePeter Glazer | TypeConflict of Interest | CompanyPatrys Limited | Disclosed Value$20,000 - $39,999 | Year Filed2016 |
NamePeter Glazer | TypeConflict of Interest | CompanyPatrys, Limited | Disclosed Value$20,000 - $39,999 | Year Filed2017 |
NameKathleen Carroll | TypeConflict of Interest | CompanyCBT4CBT, LLC | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameKathleen Carroll | TypeConflict of Interest | CompanyCBT4CBT, LLC | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyMedtronic Diabetes | Disclosed Value$20,000 - $39,999 | Year Filed2014 |
NamePeter Glazer | TypeConflict of Interest | CompanyTruCode Gene Repair, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2019 |
NamePeter Glazer | TypeConflict of Interest | CompanyTru Code (formerly PNA Innovations) | Disclosed Value$20,000 - $39,999 | Year Filed2017 |
NameW. Mark Saltzman | TypeConflict of Interest | CompanyTru Code (formerly PNA Innovations) | Disclosed Value$20,000 - $39,999 | Year Filed2017 |
NameLieping Chen | TypeConflict of Interest | CompanyBristol-Myers Squibb, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2015 |
NamePeter Glazer | TypeConflict of Interest | CompanyTruCode | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameW. Mark Saltzman | TypeConflict of Interest | CompanyTruCode | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameMarie Egan | TypeConflict of Interest | CompanyTru Code (formerly PNA Innovations, Inc.) | Disclosed Value$20,000 - $39,999 | Year Filed2017 |
NameKathleen Carroll | TypeConflict of Interest | CompanyCBT4CBT, LLC | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameKathleen Carroll | TypeConflict of Interest | CompanyCBT4CBT, LLC. | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyGrove Instruments | Disclosed Value$20,000 - $39,999 | Year Filed2014 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyInsuline Medical, Ltd. | Disclosed Value$20,000 - $39,999 | Year Filed2013 |
NameDaniel Geschwind | TypeConflict of Interest | CompanySynapDX | Disclosed Value$20,000 - $39,999 | Year Filed2013 |
NameJean-Francois Geschwind | TypeConflict of Interest | CompanyLaboratoire Guerbet | Disclosed Value$20,000 - $39,999 | Year Filed2015 |
NameLieping Chen | TypeConflict of Interest | CompanyBristol Meyers Squibb, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2012 |
NameLieping Chen | TypeConflict of Interest | CompanyAstraZeneca Pharmaceuticals | Disclosed Value$20,000 - $39,999 | Year Filed2015 |
NameStephen Strittmatter | TypeConflict of Interest | CompanyAxerion Therapeutics, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2016 |
NameJean-Francois Geschwind | TypeConflict of Interest | CompanyPhilips HealthCare | Disclosed Value$20,000 - $39,999 | Year Filed2015 |
NameW. Mark Saltzman | TypeConflict of Interest | CompanyTruCode Gene Repair, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2019 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyInsuline Medical, Ltd. | Disclosed Value$20,000 - $39,999 | Year Filed2013 |
NamePeter Glazer | TypeConflict of Interest | CompanyCybrexa Therapeutics | Disclosed Value$20,000 - $39,999 | Year Filed2017 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyBristol-Myers Squibb | Disclosed Value$20,000 - $39,999 | Year Filed2014 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyGrove Instruments | Disclosed Value$20,000 - $39,999 | Year Filed2014 |
NameSherry McKee | TypeConflict of Interest | CompanyCerecor, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2016 |
NameMarie Egan | TypeConflict of Interest | CompanyTruCode | Disclosed Value$20,000 - $39,999 | Year Filed2018 |
NameWilliam Tamborlane | TypeConflict of Interest | CompanyNovo Nordisk Pharmaceuticals | Disclosed Value$20,000 - $39,999 | Year Filed2014 |
NameMarie Egan | TypeConflict of Interest | CompanyPNA Innovations, Inc. | Disclosed Value$20,000 - $39,999 | Year Filed2017 |
NameSarah Goldberg | TypeConflict of Interest | CompanyAstraZeneca | Disclosed Value$10,000 - $19,999 | Year Filed2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.